FDA grants approval for generic lansoprazole

Genéricos/Novedades | Posted 03/12/2010 post-comment0 Post your comment

Teva Pharmaceutical Industries announced on 18 October 2010 that it had received FDA approval for its Abbreviated New Drug Application for its generic version of Takeda's Prevacid (lansoprazole) SoluTab.

picture40

The Israeli generics’ giant has been granted permission to market the drug in the US, and shipment of the medication has already commenced.

Lansoprazole, which is a proton pump inhibitor, is used to treat and prevent stomach and intestinal ulcers by lowering the amount of stomach acid produced by the body.

Annual sales of Prevacid were estimated to be US$453 million in the US, according to IMS sales data.

Source: Teva Press Release. Teva Announces Launch of Generic Prevacid® SoluTab in the United States. 18 October 2010.

comment icon Comments (0)
Post your comment
Most viewed articles
Sobre GaBI
INICIO/Sobre GaBI Posted 06/08/2009
EU guidelines for biosimilars
EMA logo 1 V13C15
INICIO/Directrices Posted 08/10/2010